IP Library Patent Application 16530946
Patent Application
App. No. 16/530,946

TRISPECIFIC ANTIBODIES

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/530,946
Abstract

Provided herein are trispecific antibodies that include a) a first monomer, b) a second monomer, and c) a light chain. The first monomer includes a first variant Fc domain and a variable heavy domain, the second monomer includes a second variant Fc domain and a first scFv domain and the light chain includes a variable light domain. The variable heavy domain and the variable light domain form an antigen binding domain. The trispecific antibody further includes a second scFv domain on either the first or second monomers.

Claims (20)

1 . A trispecific antibody comprising:

a) a first monomer comprising a first heavy chain comprising a first variant Fc domain and a first variable heavy domain;

b) a second monomer comprising:

i) a second variant Fc domain;

ii) a first scFv domain; and

c) a light chain comprising a constant light domain and a variable light domain;

wherein the first variable heavy domain and the first variable light domain form an antigen binding domain, and

wherein one of the first and second monomers further comprises a second scFv domain.

2 . The trispecific antibody of claim 1 , wherein the first monomer comprises the second scFv domain.

3 . The trispecific antibody of claim 1 , wherein the second monomer comprises the second scFv domain.

4 . A nucleic acid composition comprising:

a) a first nucleic acid encoding the first monomer of claim 1 ;

b) a second nucleic acid encoding the second monomer of claim 1 ; and

c) a third nucleic acid encoding the third monomer of claim 1 .

5 . An expression vector composition comprising:

a) a first expression vector comprising the first nucleic acid of claim 4 ;

b) a second expression vector comprising the second nucleic acid of claim 4 ; and

c) a third expression vector comprising the third nucleic acid of claim 4 .

6 . A host cell comprising the expression vector composition of claim 5 .

7 . A method of making a trispecific antibody comprising culturing the host cell of claim 6 under conditions wherein the trispecific antibody is expressed and recovering the trispecific antibody.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 13, 2019
From: MOORE, GREGORY; CHU, SEUNG; DESJARLAIS, JOHN; LEE, SUNG-HYUNG
To: XENCOR, INC.
Reel/Frame 050043/0326 →